![Richard Michael Condon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Michael Condon
Chief Executive Officer at
Aspire Pharma Ltd.
Profile
Richard Michael Condon currently works at Aspire Pharma Ltd., as Chief Executive Officer & Director from 2022 and Morningside Healthcare Ltd., as Director from 2022.
Richard Michael Condon active positions
| Companies | Position | Start |
|---|---|---|
Morningside Healthcare Ltd.
 Morningside Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Director/Board Member | 29/09/2022 |
Aspire Pharma Ltd.
 Aspire Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops, licenses and sells pharmaceutical products | Chief Executive Officer | 31/03/2022 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Morningside Healthcare Ltd.
Morningside Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Aspire Pharma Ltd.
Aspire Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops, licenses and sells pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Richard Michael Condon
